Pregnancy and the Use of Disease-Modifying Therapies in Patients with Multiple Sclerosis: Benefits versus Risks.

Alroughani, Raed; Altintas, Ayse; Al Jumah, Mohammed; Sahraian, Mohammadali; Alsharoqi, Issa; AlTahan, Abdurahman; Daif, Abdulkader; Dahdaleh, Maurice; Deleu, Dirk; Fernandez, Oscar; Grigoriadis, Nikolaos; Inshasi, Jihad; Karabudak, Rana; Taha, Karim; Totolyan, Natalia; Yamout, Bassem I; Zakaria, Magd; Bohlega, Saeed

Alroughani, Raed; Altintas, Ayse; Al Jumah, Mohammed; Sahraian, Mohammadali; Alsharoqi, Issa; AlTahan, Abdurahman; Daif, Abdulkader; Dahdaleh, Maurice; Deleu, Dirk; Fernandez, Oscar; Grigoriadis, Nikolaos; Inshasi, Jihad; Karabudak, Rana; Taha, Karim; Totolyan, Natalia; Yamout, Bassem I; Zakaria, Magd; Bohlega, Saeed.

Afiliação

Alroughani R; Division of Neurology, Amiri Hospital and Division of Neurology, Dasman Diabetes Institute, Dasman, Kuwait.
Altintas A; Division of Neurology, Cerrahpasa School of Medicine, Istanbul University, Istanbul, Turkey.
Al Jumah M; King Abdullah International Medical Research Center, King Saud Ben Abdulaziz University for Health Sciences, NGHA, Riyadh, Saudi Arabia; KFMC, Ministry of Health, Riyadh, Saudi Arabia.
Sahraian M; MS Research Center, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran.
Alsharoqi I; Clinical Neurosciences Department, Salmaniya Medical Complex, Manama, Bahrain.
AlTahan A; Neurology Section, King Khalid University Hospital, King Saud University and Dallah Hospital, Riyadh, Saudi Arabia.
Daif A; King Khalid University Hospital, King Saud University, Riyadh, Saudi Arabia.
Dahdaleh M; Department of Internal Medicine, Neurology Section, Arab Medical Center and Khalidi Hospital, Amman, Jordan.
Deleu D; Department of Neurology (Medicine), Hamad Medical Corporation, Doha, Qatar.
Fernandez O; Instituto de Investigación Biomédica de Málaga (IBIMA), Hospital Regional Universitario, Málaga, Spain.
Grigoriadis N; Laboratory of Experimental Neurology and Neuroimmunology, Multiple Sclerosis Center, 2nd Department of Neurology, AHEPA University Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece.
Inshasi J; Neurology Department, Rashid Hospital and Dubai Medical College, Dubai Health Authority, Dubai, UAE.
Karabudak R; Department of Neurology, Neuroimmunology Unit, Hacettepe University Hospitals, Ankara, Turkey.
Taha K; Merck, Intercontinental Region, Dubai, UAE.
Totolyan N; Department of Neurology, 1st St. Petersburg State Medical University n.a. I.P. Pavlov, St. Petersburg, Russia.
Yamout BI; Multiple Sclerosis Center, American University of Beirut Medical Center, Beirut, Lebanon.
Zakaria M; Faculty of Medicine, Ain Shams University, Cairo, Egypt.
Bohlega S; Department of Neurosciences, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia.

Mult Scler Int ; 2016: 1034912, 2016.

Article em En | MEDLINE | ID: mdl-28078140

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Guideline / Risk_factors_studies Idioma: En Revista: Mult Scler Int Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Kuait

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google